Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2022-01-03 00:00:00 ET · period of report 2021-12-29 · accession 0000899243-22-000188 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-03 | 2021-12-29+ | BBIO | Lo Andrew | Dir | P - Purchase | $13.18 | +7,500 | 46.6K | +19% | +$98.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-30 | P | A | 1,500 | $14.30 | 48,099 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-29 | P | A | 6,000 | $12.90 | 46,599 | D | — | — |